In support of this concept, an examination of 59 hormone naive and 20 hormone refractory (CRPC) tumors using immunohistochemistry demonstrated a heterogeneous pattern of AR expression in both hormone naive PC and CRPC with approximately 25% of tumor cells being AR negative [152]. This evidence concerns the gene AR and neoplasm.